Caroline Struyfs

Mrs. Caroline Struyfs

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
KVKim Vriens
Kim Vriens
PKPhalguni Tewari Kumar
Phalguni Tewari Kumar
CSCaroline Struyfs
Caroline Struyfs
TCTanne L. Cools
Tanne L. Cools
PSPieter Spincemaille
Pieter Spincemaille
KTKarin Thevissen
Karin Thevissen
Amphotericin B (AmB) induces oxidative and nitrosative stresses, characterized by production of reactive oxygen and nitrogen species, in fungi. Yet, how these toxic species contribute to AmB‐induced fungal cell death is unclear. We investigated the role of superoxide and nitric oxide radicals in AmB’s fungicidal activity in Saccharomyces cerevisiae, using a digital microfluidic platform, which enabled monitoring individual cells at a spatiotemporal resolution, and plating assays. The nitric oxide synthase inhibitor L‐NAME was used to interfere with nitric oxide radical production. L‐NAME increased and accelerated AmB‐induced accumulation of superoxide radicals, membrane permeabilization, and loss of proliferative capacity in S. cerevisiae. In contrast, the nitric oxide donor S‐nitrosoglutathione inhibited AmB’s action. Hence, superoxide radicals were important for AmB’s fungicidal action, whereas nitric oxide radicals mediated tolerance towards AmB. Finally, also the human pathogens Candida albicans and Candida glabrata were more susceptible to AmB in the presence of L‐NAME, pointing to the potential of AmB‐L‐NAME combination therapy to treat fungal infections.

7 January 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JBJolien Breukers
Jolien Breukers
SHSara Horta
Sara Horta
CSCaroline Struyfs
Caroline Struyfs
DSDragana Spasic
Dragana Spasic
HFHendrik B. Feys
Hendrik B. Feys
Jeroen LammertynJeroen Lammertyn
Jeroen Lammertyn


25 April 2025 in EBioMedicine
Verified
Journal Article
Open access
CSCaroline Struyfs
Caroline Struyfs
KHKlaas Van Den Heede
Klaas Van Den Heede
LWLiesbeth Van Wesenbeeck
Liesbeth Van Wesenbeeck
AWAdam Tully Waickman
Adam Tully Waickman
FRFreya Rasschaert
Freya Rasschaert
Ole LagatieOle Lagatie
Ole Lagatie
According to WHO, dengue is one of the top ten global health threats, with almost half of the world's population at risk of being infected. Most of the annual 400 million dengue virus (DENV) infections manifest asymptomatically or in a mild form, causing symptoms such as fever and headache. Nevertheless, every year 500,000 dengue cases require hospitalization and up to 25,000 patients die. Despite the high incidence, the DENV-elicited proteome response remains insufficiently understood. Therefore, we evaluated the proteome dynamics of nine dengue-naïve individuals experimentally infected with the underattenuated DENV-1 strain 45AZ5 via the Proximity Extension Assay technology of Olink®. Using Olink Explore, a total of ∼3000 proteins were quantified simultaneously in serum samples at 8, 10, 14, and 28 days after the viral inoculation. We identified the top ten significant proteins via linear mixed effects models, i.e., interferons (IFNs), IFN-related proteins, and members of the CCL and CXCL chemokine family. In all participants, an increase in IFN-λ1 levels was observed after peak viral load, whereas in one participant an IFN-γ response was not detected. Interestingly, both the onset and peak viral load of this participant were, on average, delayed 4 days compared to other participants. To gain a detailed kinetic overview of the DENV-elicited proteome response, we designed a smaller, targeted Olink® panel to evaluate serum protein levels at multiple time points throughout the infection. Here, we revealed that type I/III IFN response precedes the type II IFN response. In conclusion, our analyses provided detailed insights into the temporal dynamics of the different IFN responses upon a primary DENV-1 infection. These insights might aid in better understanding dengue pathogenesis. Funding for this research was provided by Johnson and Johnson, the State of New York, and the Congressionally Directed Medical Research Programs.

Verified
Journal Article
Open access
PDF file
CSCaroline Struyfs
Caroline Struyfs
JBJolien Breukers
Jolien Breukers
DSDragana Spasic
Dragana Spasic
Jeroen LammertynJeroen Lammertyn
Jeroen Lammertyn
BCBruno Cammue
Bruno Cammue
KTKarin Thevissen
Karin Thevissen
Single cell analyses have gained increasing interest over bulk approaches because of considerable cell-to-cell variability within isogenic populations. Herein, flow cytometry remains golden standard due to its high-throughput efficiency and versatility, although it does not allow to investigate the interdependency of cellular events over time. Starting from our microfluidic platform that enables to trap and retain individual cells on a fixed location over time, here, we focused on unraveling kinetic responses of single Saccharomyces cerevisiae yeast cells upon treatment with the antifungal plant defensin HsAFP1. We monitored the time between production of reactive oxygen species (ROS) and membrane permeabilization (MP) in single yeast cells for different HsAFP1 doses using two fluorescent dyes with non-overlapping spectra. Within a time frame of 2 min, only <0.3% cells displayed time between the induction of ROS and MP. Reducing the time frame to 30 s did not result in increased numbers of cells with time between these events, pointing to ROS and MP induction as highly dynamic and correlated processes. In conclusion, using an in-house developed continuous microfluidic platform, we investigated the mode of action of HsAFP1 at single cell level, thereby uncovering the close interdependency between ROS induction and MP in yeast.

1 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
Thomas Wolf VerdoncktThomas Wolf Verdonckt
Thomas Wolf Verdonckt
MSM. Sahulčík
M. Sahulčík
CSCaroline Struyfs
Caroline Struyfs
AVA.S. Vermeersch
A.S. Vermeersch
KBKoen Bartholomeeusen
Koen Bartholomeeusen
KAKevin Arien
Kevin Arien
Bulk B- and T-cell adaptive immune receptor (BCR/TCR) repertoire sequencing (AIRRseq) enables comprehensive analysis of adaptive immune diversity, but achieving balanced sequencing depth across heterogeneous clinical samples remains a major cost driver. Standard equimolar pooling prior to sequencing disproportionately allocates reads, leading to undersequencing of libraries with high sequence abundance and oversampling of those with few sequences. Here, a quantitative pooling strategy is described in which libraries are pooled based on estimated target-specific unique molecular identifier (UMI) counts rather than library molarity, ensuring a uniform number of supporting reads per target sequence UMI across samples. Libraries were prepared from human RNA using the NEBNext Immune Sequencing (IS) kit and quantified by qPCR during the second amplification (PCR2) step. Deeply sequenced samples from a dengue 1 human infection model (DHIM1) clinical study were used to model the log-linear relationship between PCR2 cycle threshold (Ct) values and detected sequence counts. This model was then applied to a second, independent batch of samples from a dengue 3 human infection model (DHIM3) clinical study to predict UMI abundance and guide equi-depth pooling prior to sequencing. Sequencing of these equi-depth pools demonstrated a near-uniform reads-per-sequence ratio across samples, confirming that this approach achieves balanced depth without oversampling and at reduced cost. Simulations across a range of between-sample UMI-count distributions reflecting real-world sample pools showed that equi-depth pooling is expected to reduce the total number of required sequencing reads by approximately 70% compared with equimolar pooling, with savings increasing as the spread of library sizes grows. Beyond cost efficiency, equi-depth pooling eliminates the complexity-dependent sampling bias inherent to equimolar pooling, ensuring uniform sequencing depth and comparable UMI recovery across small and large libraries. For new workflows or sample types, implementation requires either an existing calibration dataset or a pilot sequencing experiment to establish the relationship between PCR2 Ct values and relative UMI abundance. The equi-depth method thus provides a robust, scalable, and cost-efficient strategy for bulk AIRRseq studies where library sizes vary widely.